SCHEDULE: T. Rowe Price Discloses Stake in US Antimony Corp

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.8% of United States Antimony Corp.'s common stock as of June 30, 2026.

Summary

• T. Rowe Price Associates, Inc. has filed a Schedule 13G, indicating a change in its beneficial ownership of United States Antimony Corp. common stock.
• As of June 30, 2026, T. Rowe Price Associates, Inc. beneficially owns 10,031,734 shares, representing 6.8% of the class.
• The filing confirms T. Rowe Price Associates, Inc. has sole voting power over 10,021,806 shares and sole dispositive power over 10,031,734 shares.
• This filing is made under Rule 13d-1(b) and T. Rowe Price Associates, Inc. certifies that the securities were acquired in the ordinary course of business and not for the purpose of influencing control.
• T. Rowe Price Associates, Inc. expressly denies beneficial ownership beyond what is stated.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it primarily reports a change in beneficial ownership without providing new operational or financial performance data.

Positives

• Increased institutional interest, as indicated by T. Rowe Price's stake, can sometimes signal confidence in a company's long-term prospects.
• The filing confirms T. Rowe Price Associates, Inc. has significant sole voting and dispositive power, suggesting a clear investment position.

Negatives

• The filing does not provide any new operational or financial performance data for United States Antimony Corp.
• The disclosure is a standard Schedule 13G filing, which primarily reports ownership levels and does not inherently signal positive company performance.

Risks

• The filing does not explicitly mention any risks associated with United States Antimony Corp.'s business operations or market conditions.
• Potential for future changes in T. Rowe Price Associates, Inc.'s ownership stake, which could impact market dynamics.

Future Outlook

No forward-looking statements or guidance are provided in this Schedule 13G filing.

Management Comments

• T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

Industry Context

StockSavvy.ai notes that this filing indicates significant institutional interest in United States Antimony Corp., a company operating in the specialized antimony market. The antimony market is influenced by demand from industries such as flame retardants, batteries, and alloys.

Stakeholder Impact

• Shareholders may view increased institutional ownership as a positive sign, potentially leading to greater market liquidity and stability.
• The market may react to the increased disclosure of ownership, potentially influencing trading activity.

Next Steps

• Monitor future filings from T. Rowe Price Associates, Inc. for any changes in their beneficial ownership of United States Antimony Corp.

Key Dates

Keywords

Antimony, Mining, Investment, Ownership, Beneficial Ownership, Schedule 13G, Institutional Investor